title: Macrophage activation syndrome revealing disseminated tuberculosis in a patient on infliximab.
authors.forename: Vincent
authors.initials: V
authors.lastname: André
authors.forename: Charly
authors.initials: C
authors.lastname: Liddell
authors.forename: Thomas
authors.initials: T
authors.lastname: Guimard
authors.forename: Gilles
authors.initials: G
authors.lastname: Tanguy
authors.forename: Grégoire
authors.initials: G
authors.lastname: Cormier
mesh_terms: D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D017809:Fatal Outcome; D006801:Humans; D000069285:Infliximab; D055501:Macrophage Activation Syndrome / Q000209:etiology*; D008297:Male; D014376:Tuberculosis / Q000175:diagnosis* / Q000209:etiology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab